MedTrace Logo

ASIAN HF Registry, A Prospective Observational Study

NCT01633398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6329

Last updated 2021-07-14

Study results available
· View outcomes & findings →

Summary

The ASIAN HF Registry is the first prospective multinational Asian registry of patients with symptomatic HF (stage C) including both HFrEF (ejection fraction \<40%) and HFpEF (ejection fraction ≥50%), with the broad purpose of determining the mortality (incidence) burden of HF in Asian patients, and more specifically to define the burden and risk factors of Sudden Cardiac Deaths (SCD), as well as the sociocultural barriers to preventive device therapy. The study further aim to study the genetic variants associated with HFrEF versus HFpEF in our large Asian cohort.

This proposed registry is expected to advance fundamental understanding of the burden and predictors of preventable death among Asian patients with HF. The knowledge gained will be critical for guiding resource allocation and planning preventive strategies to address the unmet and growing clinical needs of patients with cardiovascular disease in Asia.

Conditions

Interventions

GENETIC

Saliva Genetic testing

To compare the genetic variants between the two phenotypes of reduced versus preserved ejection fraction (HFrEF versus HFpEF)

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Bayer

    collaborator INDUSTRY

  • National Medical Research Council (NMRC), Singapore

    collaborator OTHER_GOV

  • Agency for Science, Technology and Research (A*STAR)

    collaborator OTHER_GOV

  • Carolyn Lam

    lead OTHER

Principal Investigators

  • Carolyn Lam, M.D. · National University Heart Center (NUHC)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2020-03-06
Completion
2020-03-06

Countries

  • China
  • Hong Kong
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01633398 on ClinicalTrials.gov